BiosanaPharma Sees Success In Omalizumab Trial

Phase I Study Shows Favorable Comparison To Novartis' Xolair Brand

 
• By David Wallace
84
The Omalizumab Trial Involved 84 Volunteers • Source: Shutterstock

More from Biosimilars

More from Products